Nuvation Bio, Inc. (NUVB)
3.99
-0.07
(-1.72%)
USD |
NYSE |
Nov 13, 16:00
3.98
-0.01
(-0.25%)
Pre-Market: 19:59
Nuvation Bio Debt to Equity Ratio : 2.053 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 2.053 |
| June 30, 2026 | 1.640 |
| March 31, 2026 | 0.679 |
| December 31, 2025 | 0.6959 |
| September 30, 2025 | 0.6387 |
| June 30, 2025 | 0.5454 |
| March 31, 2025 | 0.0272 |
| December 31, 2024 | 0.0192 |
| September 30, 2024 | 0.0223 |
| June 30, 2024 | 1.126 |
| March 31, 2024 | 0.0059 |
| December 31, 2023 | 0.0066 |
| September 30, 2023 | 0.0073 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.0059 |
| March 31, 2023 | 0.0062 |
| December 31, 2022 | 0.0065 |
| September 30, 2022 | 0.0067 |
| June 30, 2022 | 0.0068 |
| March 31, 2022 | 0.0038 |
| December 31, 2021 | 0.0041 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 3.333 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Pfizer Inc. | 0.7042 |
| Johnson & Johnson | 0.5477 |
| Merck & Co., Inc. | 1.198 |
| Bristol Myers Squibb Co. | 1.915 |
| ANI Pharmaceuticals, Inc. | 0.9531 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 778.39M |
| Total Liabilities (Quarterly) | 550.42M |
| Shareholders Equity (Quarterly) | 227.98M |
| Current Ratio | 7.454 |
| Net Debt Paydown Yield | -2.68% |